Evidence map›Paper›PMID 35929101›Full record

ArticleCancer communications (London, England)2022

A serum microRNA signature for enhanced selection of people for lung cancer screening.

Haixin Yu, Janhavi R Raut, Megha Bhardwaj, Yan Zhang, Evelin Sandner, Ben Schöttker, Bernd Holleczek, Petra Schrotz-King, Hermann Brenner

Abstract readLetter
In one paragraph

Article in Cancer communications (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Updates in Lung Cancer Screening: A Decade of Evidence.Seminars in respiratory and critical care medicine · 2025
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Haixin YuDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, 69120, Baden-Württemberg, Germany.
Janhavi R RautMedical Faculty Heidelberg, University of Heidelberg, Heidelberg, 69120, Baden-Württemberg, Germany.ORCID 0000-0001-6537-8598
Megha BhardwajDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, 69120, Baden-Württemberg, Germany.
Yan ZhangDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, 69120, Baden-Württemberg, Germany.
Evelin SandnerPneumology and Thoracic Oncology, Robert-Bosch Krankenhaus, Klinik Schillerhoehe, Gerlingen, 70839, Baden-Württemberg, Germany.
Ben SchöttkerDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, 69120, Baden-Württemberg, Germany.
Bernd HolleczekSaarland Cancer Registry, Präsident-Baltz-Straße 5, Saarbrucken, 66119, Saarland, Germany.
Petra Schrotz-KingDivision of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, 69120, Baden-Württemberg, Germany.
Hermann BrennerDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, 69120, Baden-Württemberg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsMicroRNAsBiomarkers, TumorEarly Detection of CancerHumansBiomarkers, TumorMicroRNAs

Identifiers

PMID35929101
PMCPMC9648391

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.